
Banking and insurance will remain the bulwark of Persistent Systems' growth in the near future, as healthy deal wins across the US and Europe offset weakness in certain pockets of the healthcare and life sciences business. According to CEO and Executive Director Sandeep Kalra, the company has good traction in banking across the US and in Europe, with deals that should translate into higher revenues. BFSI contributed 34% to the topline in Q1, up from 31.6% two years ago, while healthcare slipped to 25.3% from 27.3% over the same period. The company expects fairly decent growth in segments like scientific instruments, medical devices, pharma and payer outside the lumpy provider segment. Software, high-tech and emerging industries contributed about 41% to the revenue mix.
Persistent Systems achieved a record quarterly Total Contract Value (TCV) of $1.15 billion in Q1 FY27, reflecting continued momentum in larger client engagements. As per the latest exchange filing, the company secured a 6.5-year strategic services agreement with a leading global technology company valued at more than $650 million, demonstrating strong client confidence and market positioning. The large deal will focus on product development, product support, cloud services operations and support, with Kalra describing it as a cost-reduction play under which Persistent will take over the development support of a certain number of software-as-a-service (SaaS) products from an operations perspective and deliver the same at a lower cost. The company's Annual Contract Value (ACV) rose 20.6% sequentially to $536.8 million, indicating robust future revenue visibility.
Persistent Systems reported mixed Q1 FY27 results with consolidated net profit rising 13.67% year-on-year to ₹483.04 crore compared to ₹424.93 crore in the same quarter last year. The company also showed robust sequential growth with revenue from operations rising 29% quarter-on-quarter to ₹4,303.22 crore from ₹3,333.58 crore in Q1 FY25. In constant currency terms, revenue grew 16.5%, one of the highest among IT services providers. However, EBIT declined 11.8% to ₹582 crore, while EBIT margin contracted to 16.0% from 16.3% in the previous quarter, missing Prabhudas Lilladher's estimate of 16.5%. The decline was primarily attributed to forex losses of ₹105.2 crore during the quarter, compared with a forex gain of ₹1.1 crore in the March quarter, along with a 40% sequential increase in other expenses. Despite margin pressure, the company delivered constant currency revenue growth of 4.1%, ahead of expectations and an improvement from 3.4% in the previous quarter.
Persistent Systems has signed a Business Combination Agreement with Nagarro, a Frankfurt-listed European digital engineering firm, as part of its merger and acquisition strategy. The transaction involves acquiring German digital engineering company Nagarro for more than €1 billion in June, which will help build a bigger presence in Europe as the company looks to reduce its overdependence on the US, which now contributes four-fifths of its revenue. The open offer document has been submitted to Germany's financial regulator BaFin for review, while an application has been filed with the Reserve Bank of India (RBI) for approval. The company expects the transaction to close in Q4 CY2026 or Q1 CY2027, subject to regulatory approvals and customary closing conditions. The acquisition will take a few more months to realise the benefits as it awaits approvals from regulators and shareholders.
ICICI Securities has maintained a 'Hold' rating on Persistent Systems with a revised target price of ₹5,280 in its latest research report dated August 4, 2026. The brokerage firm assigned a 32x multiple to FY28E EPS to arrive at the target price, up from its previous 30x multiple. The upgrade comes despite the stock's recent underperformance, with Persistent Systems shares falling as much as 3.86% to an intraday low of ₹5,335.25 on the BSE following the Q1 FY27 results release. At 9:36 am, the stock was trading 3.25% lower at ₹5,369.50, significantly underperforming the BSE Sensex which was up 0.67% at 78,620. The market reaction reflects investor concerns over margin compression despite steady revenue growth, with the stock movement indicating disappointment over profitability metrics that missed analyst expectations.